Genmab — Juli 2020
-
PS: Jeg kan forstå, at jeg ikke er den eneste i denne chat der har et rigtigt arbejde om søndagen.
-
PS: Vi arbejder på sitet i aften og nat. Beklager udfald og mærkeligt udseende sider.
-
God morgen.
-
Servicemeddelelse: Bemærk at du via vores menulinje kan klikke dig direkte ind på Proinvestors Aktiesnak, Genmab Shareholders, Proinvestors pharma- og bioteksnak og vore Aktiebar på Facebook
-
Korea SC approval http://www.koreabiomed.com/news/articleView.html?idxno=8680
-
Thanks E L.
-
Stroka..Vi røg dog hurtigt ned igen i et kendt tradingrange.
-
Efstathios Kastritis, EHA 2020: CYBORD in Amyloidosis and The ANDROMEDA Study https://www.youtube.com/watch?v=kzPq9KWugSE
-
Zeal, Bava, Novo og Gen er i rødt efter en fin start på dagen.
-
Går mod opgang på Wall Street – fremtidsindeksene stiger markant.https://investor.dn.no/#!/Oversikt/Direkte/57349
-
Bloomberg Markets
@markets
·
22 min
#5things
-Covid cases still rising
-Growth outlook worsens
-China shares surge
-Markets rally
-Coming up...
https://bloom.bg/3e3KU6G -
ADC Therapeutics Announces U.S. Food and Drug Administration Has Lifted Partial Clinical Hold on Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine https://news.yahoo.com/adc-therapeutics-announces-u-food-113000576.html
-
"Camidanlumab tesirine (Cami, formerly ADCT-301) is an antibody drug conjugate (ADC) comprised of a monoclonal antibody that binds to CD25 (HuMax
-TAC, licensed from Genmab A/S), conjugated to the pyrrolobenzodiazepine (PBD) dimer payload, tesirine".
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind